212 related articles for article (PubMed ID: 30537190)
1. Combined treatment with systemic resveratrol and resveratrol preconditioned mesenchymal stem cells, maximizes antifibrotic action in diabetic cardiomyopathy.
ShamsEldeen AM; Ashour H; Shoukry HS; Fadel M; Kamar SS; Aabdelbaset M; Rashed LA; Ammar HI
J Cell Physiol; 2019 Jul; 234(7):10942-10963. PubMed ID: 30537190
[TBL] [Abstract][Full Text] [Related]
2. Antioxidant Sirt1/Akt axis expression in resveratrol pretreated adipose-derived stem cells increases regenerative capability in a rat model with cardiomyopathy induced by diabetes mellitus.
Chen TS; Chuang SY; Shen CY; Ho TJ; Chang RL; Yeh YL; Kuo CH; Mahalakshmi B; Kuo WW; Huang CY
J Cell Physiol; 2021 Jun; 236(6):4290-4302. PubMed ID: 33421145
[TBL] [Abstract][Full Text] [Related]
3. Protective effect of autologous transplantation of resveratrol preconditioned adipose-derived stem cells in the treatment of diabetic liver dysfunction in rat model.
Chen TS; Ju DT; Day CH; Yeh YL; Chen RJ; Viswanadha VP; Chang RL; Lin YC; Yao CH; Huang CY
J Tissue Eng Regen Med; 2019 Sep; 13(9):1629-1640. PubMed ID: 31216096
[TBL] [Abstract][Full Text] [Related]
4. Diazoxide preconditioning of endothelial progenitor cells from streptozotocin-induced type 1 diabetic rats improves their ability to repair diabetic cardiomyopathy.
Ali M; Mehmood A; Anjum MS; Tarrar MN; Khan SN; Riazuddin S
Mol Cell Biochem; 2015 Dec; 410(1-2):267-79. PubMed ID: 26359087
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stem cells ameliorate myocardial fibrosis in diabetic cardiomyopathy via the secretion of prostaglandin E2.
Jin L; Zhang J; Deng Z; Liu J; Han W; Chen G; Si Y; Ye P
Stem Cell Res Ther; 2020 Mar; 11(1):122. PubMed ID: 32183879
[TBL] [Abstract][Full Text] [Related]
6. Human umbilical cord-derived mesenchymal stromal cells improve myocardial fibrosis and restore miRNA-133a expression in diabetic cardiomyopathy.
Liu B; Wei Y; He J; Feng B; Chen Y; Guo R; Griffin MD; Hynes SO; Shen S; Liu Y; Cui H; Ma J; O'Brien T
Stem Cell Res Ther; 2024 Apr; 15(1):120. PubMed ID: 38659015
[TBL] [Abstract][Full Text] [Related]
7. Cardiac energy metabolism and oxidative stress biomarkers in diabetic rat treated with resveratrol.
Carolo dos Santos K; Pereira Braga C; Octavio Barbanera P; Seiva FR; Fernandes Junior A; Fernandes AA
PLoS One; 2014; 9(7):e102775. PubMed ID: 25050809
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol alleviates diabetic cardiomyopathy in rats by improving mitochondrial function through PGC-1α deacetylation.
Fang WJ; Wang CJ; He Y; Zhou YL; Peng XD; Liu SK
Acta Pharmacol Sin; 2018 Jan; 39(1):59-73. PubMed ID: 28770830
[TBL] [Abstract][Full Text] [Related]
9. Metformin impairs homing ability and efficacy of mesenchymal stem cells for cardiac repair in streptozotocin-induced diabetic cardiomyopathy in rats.
Ammar HI; Shamseldeen AM; Shoukry HS; Ashour H; Kamar SS; Rashed LA; Fadel M; Srivastava A; Dhingra S
Am J Physiol Heart Circ Physiol; 2021 Apr; 320(4):H1290-H1302. PubMed ID: 33513084
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol and insulin association reduced alveolar bone loss and produced an antioxidant effect in diabetic rats.
Cirano FR; Molez AM; Ribeiro FV; Tenenbaum HC; Casati MZ; Corrêa MG; Pimentel SP
J Periodontol; 2021 May; 92(5):748-759. PubMed ID: 32827164
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of in vivo and ex vivo pre-treated bone marrow-derived mesenchymal stem cells with resveratrol in streptozotocin-induced type 1 diabetic rats.
Khalil SG; Younis NN; Shaheen MA; Hammad SK; Elswefy SE
J Pharm Pharmacol; 2023 Sep; 75(9):1186-1197. PubMed ID: 37177978
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol increases stem cell function in the treatment of damaged pancreas.
Chen TS; Kuo CH; Day CH; Pan LF; Chen RJ; Chen BC; Padma VV; Lin YM; Huang CY
J Cell Physiol; 2019 Nov; 234(11):20443-20452. PubMed ID: 31037738
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow mesenchymal stem cells induce angiogenesis and attenuate the remodeling of diabetic cardiomyopathy.
Zhang N; Li J; Luo R; Jiang J; Wang JA
Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):104-11. PubMed ID: 18286426
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol prevents akinesia and restores neuronal tyrosine hydroxylase immunoreactivity in the substantia nigra pars compacta of diabetic rats.
Brambilla Bagatini P; Xavier LL; Neves L; Saur L; Barbosa S; Baptista PP; Augustin OA; Nunes de Senna P; Mestriner RG; Souto AA; Achaval M
Brain Res; 2014 Dec; 1592():101-12. PubMed ID: 25446006
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic effect of N, N-Diphenyl-1,4-phenylenediamine and adipose-derived stem cells coadministration on diabetic cardiomyopathy in type 1 diabetes mellitus-rat model.
Abd El-Lateef HM; Ali LS; Qahl SH; Binjawhar DN; Fayad E; Alghamdi MA; Altalhi SA; Al-Salmi FA; Shabana ES; Radwan KH; Youssef I; Shaaban S; Rashwan HM; El-Sawah SG
J Exp Zool A Ecol Integr Physiol; 2024 Jul; 341(6):647-657. PubMed ID: 38594572
[TBL] [Abstract][Full Text] [Related]
16. Preconditioning diabetic mesenchymal stem cells with myogenic medium increases their ability to repair diabetic heart.
Khan M; Ali F; Mohsin S; Akhtar S; Mehmood A; Choudhery MS; Khan SN; Riazuddin S
Stem Cell Res Ther; 2013 May; 4(3):58. PubMed ID: 23706645
[TBL] [Abstract][Full Text] [Related]
17. Activation of Wnt/β-catenin/GSK3β signaling during the development of diabetic cardiomyopathy.
Xi XH; Wang Y; Li J; Wang FW; Tian GH; Yin MS; Mu YL; Chong ZZ
Cardiovasc Pathol; 2015; 24(3):179-86. PubMed ID: 25586361
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic diabetic mesenchymal stem cells transplantation in streptozotocin-induced diabetic rat.
Dong QY; Chen L; Gao GQ; Wang L; Song J; Chen B; Xu YX; Sun L
Clin Invest Med; 2008 Dec; 31(6):E328-37. PubMed ID: 19032902
[TBL] [Abstract][Full Text] [Related]
19. Activation of nuclear β-catenin/c-Myc axis promotes oxidative stress injury in streptozotocin-induced diabetic cardiomyopathy.
Liu P; Su J; Song X; Wang S
Biochem Biophys Res Commun; 2017 Dec; 493(4):1573-1580. PubMed ID: 28989026
[TBL] [Abstract][Full Text] [Related]
20. Bone-Marrow-Derived Mesenchymal Stromal Cells (MSC) from Diabetic and Nondiabetic Rats Have Similar Therapeutic Potentials.
José VSS; Monnerat G; Guerra B; Paredes BD; Kasai-Brunswick TH; Carvalho ACC; Medei E
Arq Bras Cardiol; 2017 Dec; 109(6):579-589. PubMed ID: 29364350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
